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In the rat pheochromocytoma cell line PC 12, the effects of four volatile anesthetics (halothane, isoflurane, 
enflurane, methoxyflurane) on the K+-evoked intracellular calcium ([Caz+],) rise were investigated using the 
Ca2+-sensitive fluorescence dye fura-2. The [Ca*+], rise was depressed, at clinical concentrations, by all anes- 
thetics with almost identical aqueous It& values. The study extends to neuronal cells the observation made 
previously in cardiac tissue that volatile anesthetics may interfere with Ca *+ fluxes through voltage-gated 
channels. 
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1. INTRODUCTION 
Calcium is a key intracellular second messenger 
for signal transduction in nerve, muscle, endocrine 
and hemopoietic cells. Many Ca2+-dependent cel- 
lular processes are influenced by halogenated in- 
halation anesthetics (e.g. myocardial contractility 
[ 11, neurotransmitter release and synaptic trans- 
mission [2], neutrophil functions [3]). Indirect evi- 
dence that volatile anesthetics affect myoplasmic 
Ca2+ control could be demonstrated at the tissue 
and subcellular level by electrophysiologic and 
radioisotope techniques [ 1,4]. However, direct evi- 
dence that anesthetics significantly interfere with 
the regulation of intracellular free CaZf ([Ca”],) 
level is still limited [1,5,6]. In the cat papillary 
muscle halothane produced a dose-dependent de- 
crease in twitch tension and a decrease in [Ca2+]i 
rise measured by the Ca2+ sensitive photoprotein 
aequorin [6]. Inhibition of intracellular Ca2+ mo- 
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bilization has been observed in human polymor- 
phonuclear leukocytes exposed to the volatile 
anesthetics halothane, enflurane and isoflurane 
[3]. In a recent report it was shown that halothane 
inhibited the cholinergic-receptor-mediated 45Ca2f 
uptake into primary cultures of bovine adrenal 
medulla cells [7]. Interestingly, the authors did not 
find a depression of the K+-induced 45Ca uptake. 
This was so far the only study investigating this 
issue in cells of neuronal origin. 
The clonal rat pheochromocytoma cell line 
PC 12 exhibits properties of both adrenal chromaf- 
fin cells as well as sympathetic neurons [8]. In 
PC 12 cells the depolarization-induced transmitter 
release is mediated by a cytoplasmic [Ca”], rise 
that is extensively characterized by pharmacologi- 
cal, electrophysiological and radioisotope tech- 
niques as a Ca2+ influx through voltage-sensitive 
Ca2+ channels (VSCC) [9-131. Since we recently 
observed that volatile anesthetics affect the 
K+-evoked transmitter release from PC 12 cells 
(unpublished), we used this cell line to investigate 
the effects of the four volatile anesthetics 
halothane, isoflurane, enflurane and methoxy- 
flurane on the depolarization-evoked [Ca”], 
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changes by means of the Ca2+ sensitive fluores- 
cence dye fura- [14,15]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Halothane was obtained from Hoechst (Frank- 
furt, FRG), the other anesthetics were from Ab- 
bott (Wiesbaden, FRG). RPM1 1640 medium and 
sera were from Gibco Europe, all other buffers, 
media and medium supplements from Biochrom 
KG (Berlin). Diltiazem and verapamil were pur- 
chased from Sigma (St. Louis, MO, USA), fura- 
free acid and fura- acetoxymethyl ester 
(fura-2/AM) from Calbiochem (La Jolla, CA, 
USA), EGTA was from Fluka; other chemicals 
were of analytical grade from Merck (Darmstadt, 
FRG) or Sigma. 
2.2. Cell culture and fura- loading 
PC 12 cells (initially from Dr H. Bonisch, Wtirz- 
burg) were maintained in spinner culture flasks 
essentially as described by [16]. The culture 
medium consisted of RPM1 1640 supplemented 
with 10% horse serum, 5% fetal calf serum, 
penicillin (50 U/ml), streptomycin (50 fig/ml), and 
2 mM glutamine. An aliquot of the cell suspension 
was washed by centrifugation, cell viability was 
assessed by trypan blue exclusion (> 95% in all ex- 
periments), and cells were suspended in 
RPM1 1640 buffered with 20 mM Hepes, pH 7.3 
(1 x 10’ cells/ml), mixed with a 0.5% volume of 
1 mM fura-2/AM in dimethyl sulfoxide (DMSO). 
After incubation at 15°C for 1 h, the PC 12 cells 
were washed twice, and suspended in a modified 
Hanks’ salt solution (2 mM CaC12, 1.2 mM 
MgS04, 5 mM KCl, 25 mM Hepes, pH 7.3, with- 
out phenol red indicator) which served as the in- 
cubation medium for all fluorescence assays unless 
otherwise indicated. 
2.3. Measurement of [Ca’+/, with fura- in the 
presence and absence of anesthetics 
For measurements in the presence of anesthetics 
the Hanks’ incubation media were equilibrated by 
bubbling the media for 20 min at 32°C with an air 
stream containing the vaporized anesthetic (Drager 
vaporizers, Lubeck, FRG; 0.5-5%, v/v, for 
halothane, enflurane, isoflurane; O. l-2%) v/v, for 
methoxyflurane). The concentration of the 
anesthetics in the medium was checked with a gas 
chromatograph as described [17]. Control media 
were bubbled solely with air. 
Before the start of each experiment the PC 12 
cells were preincubated for 15 min at 32°C in 
Hanks’ medium with or without anesthetic. The 
cells (4 x 106) were quickly pelleted, resuspended 
in 1 ml fresh medium of identical anesthetic con- 
tent, and pipetted into a quartz cuvette which was 
tightly closed by a conical teflon plug. Assays were 
carried out at 32°C with a modified 4-8202-Amin- 
co-Bowman spectrofluorimeter (Silver Spring, 
MD, USA) fitted with a magnetic stirrer and a 
thermostatted cuvette holder. Intracellular fura- 
fluorescence intensity was measured at two quickly 
alternating excitation wavelengths (340/385 nm) 
and continuously recorded at 500 nm. KC1 stock 
solution (2.55 M, 20~1) and drugs dissolved in 
water were added directly to the cuvette. At the 
end of each individual trace, cells were lysed with 
0.1% Triton X-100 to yield the fluorescence signals 
at high Ca’+, followed by addition of 8 mM 
EGTA/SO mM Tris for minimal Ca2+ (< 1 nM) 
fluorescence signals. After correction for changes 
of autofluorescence, [Ca”], values were calculated 
according to the equation given in [14] using the 
340/385 nm ratio of fluorescence intensities and a 
Ca’+-dye dissociation constant (Kd) of 365 nM. 
3. RESULTS 
In the complete incubation medium containing 
5 mM K+ and 2 mM Ca2+ the [Ca”], was 
96 nM f 17 nM. Raising the extracellular concen- 
tration of K+ from 5 mM to 55 mM induced a 
marked rise in fura- fluorescence at 340 nm ex- 
citation wavelength (within 10 to 15 s), reflecting 
an increase in [Ca’+]i from the basal level to ap- 
prox. 300 nM (fig.lA,E). Within the first minute 
this peak concentration declined to a plateau level, 
which remained elevated for several minutes 
(fig.1). The extent of the measured [Ca’+]i rise 
depended on the K+ concentration, reaching a 
maximum (about 3-fold the resting level) above 
50 mM. Similar [Ca”], levels as shown here with 
fura- have been obtained with the Ca2+ indicator 
quin 2 in PC 12 cells [18,19]. 
As demonstrated in fig.lB, the K+-induced 
[Ca2’], elevation was totally dependent on the 
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Fig.1. Fura- fluorescence traces of the K+-induced 
[Ca”], rise in suspended PC 12 cells. For continuous 
registration the emitted fluorescence signal (500 nm) was 
recorded only at 340 nm excitation wavelength. Arrows 
indicate 20~1 additions of K+ or Ca’* (55 mM and 
2 mM final free concentration, respectively). The 
numbers on the left represent the [Ca”], calibration 
scale (nM). The bar indicates 3 min. The tracings 
presented are representative of at least four independent 
experiments. Panels: A,E, PC 12 cells in complete Ca2+ 
containing incubation medium (controls); B, K+-depola- 
rization in Ca2+ free incubation medium (2 mM EGTA), 
and after addition of excess Cazf; C, K+-depolarization 
in the presence of 300,~M diltiazem (15 min preincuba- 
tion) in complete incubation medium; D, dose-response 
curve for dl-verapamil. Values refer to the height of in- 
itial [Ca”], rises above resting levels produced by K+ at 
various drug concentrations, and were expressed as per- 
cent inhibition as compared with the controls (mean 
values from three different experiments, SD < 10%); 
F-H, K+-depolarization in the presence of 2% (F) and 
4% (G) halothane, and after washout of 4% halothane 
by subsequent medium exchange with anesthetic free in- 
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Fig.2. Inhibitory effects of halothane (A, solid circles), 
methoxyflurane (A, open circles), isoflurane (B, solid 
diamonds) and enflurane (B, open diamonds) on the 
[Ca”], rise in PC 12 cells. Values are expressed as per- 
cent inhibition compared with controls, and refer to the 
height of the K’-induced initial [(?a’+], rise above the 
resting levels. Data represent mean values k SD of four 
independent experiments with duplicate determinations. 
Molar anesthetic concentrations in medium are indicated 
cubation medium (H). on the abscissa in a logarithmic scale. 
presence of external Ca2+, since it did not occur in 
the Ca2+ free medium containing 2 mM EGTA. 
Readdition of Ca2’ to the cells challenged with 
55 mM K+ in the absence of external Ca2+ resulted 
in a rapid rise in [Ca2+]i (fig.lB). 
Experiments with prior addition of the Ca2+ 
channel antagonists diltiazem or verapamil 
(15 min drug exposure, 300,~M each) also in- 
dicated that the K+-evoked [Ca2’], rise cor- 
responded to a Ca2+ influx through VSCC 
(fig.lC,D). The concentrations at which verapamil 
(I& 1 ,LLM; fig.lD) and diltiazem (IGO 7pM) 
reduced the depolarization-induced [Ca”], rise 
were very similar to those reported previously for 
45Ca2+ uptake through VSCCs into PC 12 cells 
[131. 
All the anesthetics tested in this study inhibited 
the [Ca2’]i rise in a dose-dependent fashion (fig. 1, 
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panels E-G; fig.2A,B). As illustrated in fig. 1F and 
G for halothane (2% and 4% in air), the height of 
the initial [Ca”], peak was especially reduced. 
Therefore, percent inhibition values plotted on the 
dose-response curves (fig.2A,B) refer to the height 
of the K+-evoked initial [Ca”], rise in the presence 
of anesthetics. The volatile anesthetics produced 
half-maximal inhibition at almost identical con- 
centrations in the incubation medium (0.6 mM 
halothane; 0.58 mM isoflurane; 0.78 mM enflu- 
rane; 0.59 mM methoxyflurane). The two curves 
for halothane and methoxyflurane are nearly 
superimposable (fig.2A), while the dose-response 
curve of isoflurane differs at low concentrations 
from that obtained for its isomer, enflurane, which 
seems slightly less inhibitory than the other 
anesthetics (fig.2B). Almost complete depression 
of the [Ca”], rise was seen beyond 5% vaporized 
isoflurane, enflurane, halothane and beyond 2% 
methoxyflurane. Inhibition occurred within 2 min 
after exposure to the agents and proved to be easily 
reversible (fig. 1 H) by medium exchange. External 
Ca2+ was not competitive with the inhibitory effect 
(not shown), suggesting that volatile anesthetics 
and classical Ca2+ channel antagonists reduce the 
[Ca”], rise by separate mechanisms [20]. 
4. DISCUSSION 
Changes in [Ca2+], can be elicited by mobilizing 
Ca2+ from intracellular stores and/or by increas- 
ing the Ca2+ permeability of the plasma mem- 
brane. In adrenal medulla cells and in PC 12 cells 
the cholinergic-receptor-mediated Ca2+ changes 
involve both mechanisms in a complex regulatory 
system that is far from being fully understood [21]. 
By contrast, in PC 12 the K+-evoked [Ca”], rise is 
characterized pharmacologically, biochemically 
and electrophysiologically as the Ca” influx 
through VSCCs [9-131 which are regulated by pro- 
tein kinase C [19,22,23]. 
The data reported here document for the first 
time that the depolarization-evoked [Ca”], rise in 
a neurosecretory cell line is depressed by volatile 
anesthetics at clinical concentrations (< 1 mM). 
The depression was a common feature of all the 
anesthetics tested, and their molar inhibitory 
potencies were almost identical, suggesting com- 
mon target sites. That such a uniform inhibition of 
transmembrane ion transport is not an inevitable 
characteristic of volatile anesthetics has recently 
been shown for the Nat-K+-Cl- co-transporter in 
glial cells, which is competitively inhibited by small 
molecules like halothane, but not by enflurane, 
isoflurane or methoxyflurane [24]. 
The present findings in the PC 12 cell line con- 
trast with recent investigations in cultured bovine 
adrenal medulla cells that demonstrated an in- 
hibitory effect of halothane on the cholinergic- 
receptor-mediated, but not on the K+-induced 
“Ca’+ influx [7]. However, PC 12 cells differ in 
many aspects from medulla cells, particularly 
regarding the modulating role of protein kinase C 
on the VSCC activity. In PC 12 cells the activation 
of protein kinase C inhibits the [Ca”], rise induced 
by K+-depolarization [ 19,22,23], whereas in rat 
adrenal medulla cells the depolarization-evoked 
Ca 2+ influx is facilitated under similar conditions 
[25]. Furthermore, even medulla cells differ 
species-specifically in the relative contributions of 
muscarinic- or nicotinic-receptor-mediated pro- 
cesses for cholinergic responses [21,26]. Thus, the 
apparent differences in intracellular Ca2+ 
regulatory mechanisms may account for the dis- 
crepancy between our findings and data obtained 
with bovine medulla cells [7]. 
In our study the inhibitory effect could not be 
overcome by increasing external CaZt concentra- 
tions, suggesting that volatile anesthetics may in- 
teract with the VSCC in a manner that is different 
from that of classical CaZf channel antagonists 
[20]. An investigation of this phenomenon in a per- 
manent cell line of well defined properties would 
be of value in further elucidating the interference 
of volatile anesthetics with the regulation of intra- 
cellular free Ca2+ levels. 
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